Lindsay B. Hough - Related publications

Neuropharmacology and Neuroscience Albany Medical College, Albany, NY, United States 
Pain research
NOTE: We are testing a new system for identifying relevant work based on semantic analysis that identifies similarities between recently published papers and the current author's publications. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches.
50 most relevant papers in past 60 days:
Year Citation  Score
2020 Datta U, Kelley LK, Middleton JW, Gilpin NW. Positive allosteric modulation of the cannabinoid type-1 receptor (CB1R) in periaqueductal gray (PAG) antagonizes anti-nociceptive and cellular effects of a mu-opioid receptor agonist in morphine-withdrawn rats. Psychopharmacology. PMID 32857187 DOI: 10.1007/s00213-020-05650-5   
2020 Tonello R, Trevisan G, Luckemeyer D, Castro-Junior CJ, Gomez MV, Ferreira J. Phα1β, a dual blocker of TRPA1 and Cav2.2, as an adjuvant drug in opioid therapy for postoperative pain. Toxicon : Official Journal of the International Society On Toxinology. PMID 33038354 DOI: 10.1016/j.toxicon.2020.10.007   
2020 Zamanian G, Shayan M, Rahimi N, Bahremand T, Shafaroodi H, Ejtemaei-Mehr S, Aghaei I, Dehpour AR. Interaction of morphine tolerance with pentylenetetrazole-induced seizure threshold in mice: The role of NMDA-receptor/NO pathway. Epilepsy & Behavior : E&B. 112: 107343. PMID 32755816 DOI: 10.1016/j.yebeh.2020.107343   
2020 Morgan MM, Peecher DL, Streicher JM. Use of home cage wheel running to assess the behavioural effects of administering a mu/delta opioid receptor heterodimer antagonist for spontaneous morphine withdrawal in the rat. Behavioural Brain Research. 112953. PMID 33031872 DOI: 10.1016/j.bbr.2020.112953   
2020 Nazari-Serenjeh F, Zarrabian S, Azizbeigi R, Haghparast A. Effects of dopamine D1- and D2-like receptors in the CA1 region of the hippocampus on expression and extinction of morphine-induced conditioned place preference in rats. Behavioural Brain Research. 397: 112924. PMID 32976861 DOI: 10.1016/j.bbr.2020.112924   
2020 Iyer V, Slivicki RA, Thomaz AC, Crystal JD, Mackie K, Hohmann AG. The cannabinoid CB receptor agonist LY2828360 synergizes with morphine to suppress neuropathic nociception and attenuates morphine reward and physical dependence. European Journal of Pharmacology. 886: 173544. PMID 32896549 DOI: 10.1016/j.ejphar.2020.173544   
2020 Lee MT, Chen YH, Mackie K, Chiou LC. Median nerve stimulation as a non-pharmacological approach to bypass analgesic tolerance to morphine: a proof-of-concept study in mice. The Journal of Pain : Official Journal of the American Pain Society. PMID 33069869 DOI: 10.1016/j.jpain.2020.09.003   
2020 Nezamoleslami S, Sheibani M, Mumtaz F, Esmaeili J, Shafaroodi H, Dehpour AR. Lithium reverses the effect of opioids on eNOS/nitric oxide pathway in human umbilical vein endothelial cells. Molecular Biology Reports. PMID 32888132 DOI: 10.1007/s11033-020-05740-9   
2020 Foll L, Bernard. Opioid-sparing effects of cannabinoids: Myth or reality? Progress in Neuro-Psychopharmacology & Biological Psychiatry. 110065. PMID 32828853 DOI: 10.1016/j.pnpbp.2020.110065   
2020 Kasala S, Briyal S, Prazad P, Ranjan AK, Stefanov G, Donovan R, Gulati A. Exposure to Morphine and Caffeine Induces Apoptosis and Mitochondrial Dysfunction in a Neonatal Rat Brain. Frontiers in Pediatrics. 8: 593. PMID 33042927 DOI: 10.3389/fped.2020.00593   
2020 Mahmoudi D, Assar N, Mousavi Z, Katebi SN, Azizi P, Haghparast A. The orexin receptors in the ventral tegmental area are involved in the development of sensitization to expression of morphine-induced preference in rats. Behavioural Pharmacology. PMID 32925229 DOI: 10.1097/FBP.0000000000000587   
2020 Gaweda G, Iyer RP, Shaver PR, Grilo GA, Dinkins ML, Stoffel HJ, Clemens S, de Castro Brás LE. Dopamine receptor D3 agonist (Pramipexole) reduces morphine-induced cardiac fibrosis. Biochemical and Biophysical Research Communications. 529: 1080-1085. PMID 32819568 DOI: 10.1016/j.bbrc.2020.06.137   
2020 Algera MH, Olofsen E, Moss L, Dobbins RL, Niesters M, van Velzen M, Groeneveld GJ, Heuberger J, Laffont CM, Dahan A. Tolerance to opioid-induced respiratory depression in chronic high-dose opioid users: a model-based comparison with opioid-naïve individuals. Clinical Pharmacology and Therapeutics. PMID 32865832 DOI: 10.1002/cpt.2027   
2020 Busserolles J, Soussia IB, Pouchol L, Marie N, Meleine M, Devilliers M, Judon C, Schopp J, Clémenceau L, Poupon L, Chapuy E, Richard S, Noble F, Lesage F, Ducki S, et al. TREK-1 channel activation as a new analgesic strategy devoid of opioid adverse effects. British Journal of Pharmacology. PMID 32851651 DOI: 10.1111/bph.15243   
2020 Dozio V, Daali Y, Desmeules J, Sanchez JC. Deep proteomics and phosphoproteomics reveal novel biological pathways perturbed by morphine, morphine-3-glucuronide and morphine-6-glucuronide in human astrocytes. Journal of Neuroscience Research. PMID 32954564 DOI: 10.1002/jnr.24731   
2020 Kyzer JL, McGuire M, Park H, Belz TF, Bonakdar R, Janda KD, Wenthur CJ. Anti-Opioid Antibodies in Individuals Using Chronic Opioid Therapy for Lower Back Pain. Acs Pharmacology & Translational Science. 3: 896-906. PMID 33073189 DOI: 10.1021/acsptsci.0c00057   
2020 Doyle TM, Hutchinson MR, Braden K, Janes K, Staikopoulos V, Chen Z, Neumann WL, Spiegel S, Salvemini D. Sphingosine-1-phosphate receptor subtype 1 activation in the central nervous system contributes to morphine withdrawal in rodents. Journal of Neuroinflammation. 17: 314. PMID 33092620 DOI: 10.1186/s12974-020-01975-2   
2020 Gopalsamy B, Chia JSM, Farouk AAO, Sulaiman MR, Perimal EK. Zerumbone-Induced Analgesia Modulated via Potassium Channels and Opioid Receptors in Chronic Constriction Injury-Induced Neuropathic Pain. Molecules (Basel, Switzerland). 25. PMID 32858809 DOI: 10.3390/molecules25173880   
2020 Baehr CA, Huseby Kelcher A, Khaimraj A, Reed DE, Pandit SG, AuCoin D, Averick S, Pravetoni M. Monoclonal antibodies counteract opioid-induced behavioral and toxic effects in mice and rats. The Journal of Pharmacology and Experimental Therapeutics. PMID 32980813 DOI: 10.1124/jpet.120.000124   
2020 Webster LR, Hansen E, Cater J, Smith T. A Phase I Placebo-Controlled Trial Comparing the Effects of Buprenorphine Buccal Film and Oral Oxycodone Hydrochloride Administration on Respiratory Drive. Advances in Therapy. PMID 32978722 DOI: 10.1007/s12325-020-01481-0   
2020 Schmidt A, Vogel M, Baumgartner S, Wiesbeck GA, Lang U, Borgwardt S, Walter M. Brain volume changes after long-term injectable opioid treatment: A longitudinal voxel-based morphometry study. Addiction Biology. e12970. PMID 33000891 DOI: 10.1111/adb.12970   
2020 Zhang J, Yang J, Yang C, Chen T, Wang Z, Li J, Qin F, Deng Q, Zhang X. Sensitivity to Morphine Reward Associates With Gut Dysbiosis in Rats With Morphine-Induced Conditioned Place Preference. Frontiers in Psychiatry. 11: 631. PMID 33005148 DOI: 10.3389/fpsyt.2020.00631   
2020 Wang X, Tian Z, Ma J, Feng Z, Ou Y, Zhou M, Peng J, Lv Y, Gao G, Qi S. NPY alterations induced by chronic morphine exposure affect the maintenance and reinstatement of morphine conditioned place preference. Neuropharmacology. 108350. PMID 33027625 DOI: 10.1016/j.neuropharm.2020.108350   
2020 McKendrick G, Sharma S, Sun D, Randall PA, Graziane NM. Acute and chronic bupropion treatment does not prevent morphine-induced conditioned place preference in mice. European Journal of Pharmacology. 173638. PMID 33039460 DOI: 10.1016/j.ejphar.2020.173638   
2020 Beauchamp GA, Nelson LS, Perrone J, Lyons MS. A theoretical framework and nomenclature to characterize the iatrogenic contribution of therapeutic opioid exposure to opioid induced hyperalgesia, physical dependence, and opioid use disorder. The American Journal of Drug and Alcohol Abuse. 1-13. PMID 32897113 DOI: 10.1080/00952990.2020.1778713   
2020 Bubier JA, He H, Philip VM, Roy T, Hernandez CM, Bernat R, Donohue KD, O'Hara BF, Chesler EJ. Genetic variation regulates opioid-induced respiratory depression in mice. Scientific Reports. 10: 14970. PMID 32917924 DOI: 10.1038/s41598-020-71804-2   
2020 Burgstaller JM, Held U, Signorell A, Blozik E, Steurer J, Wertli MM. Increased risk of adverse events in non-cancer patients with chronic and high-dose opioid use-A health insurance claims analysis. Plos One. 15: e0238285. PMID 32925928 DOI: 10.1371/journal.pone.0238285   
2020 Neis VB, Moretti M, Rosa PB, Dalsenter Y, Werle I, Platt N, Kaufmann FN, Rosado AF, Besen MH, Rodrigues ALS. The involvement of PI3K/Akt/mTOR/GSK3β signaling pathways in the antidepressant-like effect of AZD6765. Pharmacology, Biochemistry, and Behavior. 173020. PMID 32861641 DOI: 10.1016/j.pbb.2020.173020   
2020 Gonçalves MR, da Conceição MS, Jesus CHA, Gasparin AT, Rosa ES, da Cunha JM. Spinal cannabinoid CB1 or CB2 receptors activation attenuates mechanical allodynia in streptozotocin-induced diabetic rats. Behavioural Pharmacology. PMID 32804775 DOI: 10.1097/FBP.0000000000000580   
2020 Solouki S, Vega M, Agalliu I, Abraham NE. Patient Satisfaction and Refill Rates After Decreasing Opioids Prescribed for Urogynecologic Surgery. Female Pelvic Medicine & Reconstructive Surgery. PMID 32947551 DOI: 10.1097/SPV.0000000000000929   
2020 Vengadessane A, Rajaraman JD, Raghuraman MS, Prabu RK, Damodaran S, Sabu B. Comparison of Duration of Analgesic Comparison of Duration of Analgesic Effect of Nalbuphine and Morphine as an Adjuvant to Bupivacaine in the Supraclavicular Block under Ultrasound Guidance. Anesthesia, Essays and Researches. 14: 38-41. PMID 32843790 DOI: 10.4103/aer.AER_13_20   
2020 Lam T, Hayman J, Berecki-Gisolf J, Sanfilippo P, Lubman DI, Nielsen S. Comparing rates and characteristics of emergency department presentations related to pharmaceutical opioid poisoning in Australia: a study protocol for a retrospective observational study. Bmj Open. 10: e038979. PMID 32994254 DOI: 10.1136/bmjopen-2020-038979   
2020 Rodriguez-Monguio R, Naveed M, Croci R, Gross K, Langnas E, Chen CL, Seoane-Vazquez E. Perioperative Prescribing Practices of Extended-Release Opioids in Noncancer Surgical Patients, 2015-2018. Anesthesia and Analgesia. 131: 1249-1259. PMID 32925346 DOI: 10.1213/ANE.0000000000004952   
2020 Lyle Cooper R, Thompson J, Edgerton R, Watson J, MacMaster SA, Kalliny M, Huffman MM, Juarez P, Mathews-Juarez P, Tabatabai M, Singh KP. Modeling dynamics of fatal opioid overdose by state and across time. Preventive Medicine Reports. 20: 101184. PMID 32995141 DOI: 10.1016/j.pmedr.2020.101184   
2020 Bech AB, Clausen T, Waal H, Vindenes V, Edvardsen HE, Frost J, Skeie I. Post-mortem toxicological analyses of blood samples from 107 patients receiving opioid agonist treatment: substances detected and pooled opioid and benzodiazepine concentrations. Addiction (Abingdon, England). PMID 32738014 DOI: 10.1111/add.15211   
2020 Wilbraham D, Biglan KM, Svensson KA, Tsai M, Kielbasa W. Safety, Tolerability, and Pharmacokinetics of Mevidalen (LY3154207), a Centrally Acting Dopamine D1 Receptor-Positive Allosteric Modulator (D1PAM), in Healthy Subjects. Clinical Pharmacology in Drug Development. PMID 33029934 DOI: 10.1002/cpdd.874   
2020 Hallvik SE, Johnston K, Geddes J, Leichtling G, Korthuis PT, Hartung DM. Identifying opioid dose reductions and discontinuation among patients with chronic opioid therapy. Pharmacoepidemiology and Drug Safety. PMID 32844498 DOI: 10.1002/pds.5096   
2020 Paniccia JE, Weckstein TN, Lebonville CL, Lysle DT. Female rats express heroin-induced and -conditioned suppression of peripheral nitric oxide production in response to endotoxin challenge. Brain, Behavior, and Immunity. PMID 33039661 DOI: 10.1016/j.bbi.2020.10.009   
2020 Albright DL, McDaniel J, Laha-Walsh K, Morrison B, McIntosh S. Polysubstance abuse associated with more frequent opioid use among patients in rural primary care settings. Journal of Opioid Management. 16: 283-289. PMID 32885836 DOI: 10.5055/jom.2020.0582   
2020 Soltani H, Sadat-Shirazi MS, Pakpour B, Ashabi G, Zarrindast MR. Toxic effect of calcium/calmodulin kinase II on anxiety behavior, neuronal firing and plasticity in the male offspring of morphine-abstinent rats. Behavioural Brain Research. 395: 112877. PMID 32841609 DOI: 10.1016/j.bbr.2020.112877   
2020 Grant MC, Isada T, Ruzankin P, Gottschalk A, Whitman G, Lawton JS, Dodd-O J, Barodka V. Opioid-Sparing Cardiac Anesthesia: Secondary Analysis of an Enhanced Recovery Program for Cardiac Surgery. Anesthesia and Analgesia. PMID 32889848 DOI: 10.1213/ANE.0000000000005152   
2020 Gold MS, Baron D, Bowirrat A, Blum K. Neurological correlates of brain reward circuitry linked to opioid use disorder (OUD): Do homo sapiens acquire or have a reward deficiency syndrome? Journal of the Neurological Sciences. 418: 117137. PMID 32957037 DOI: 10.1016/j.jns.2020.117137   
2020 Gao PF, Lin JY, Wang S, Zhang YF, Wang GQ, Xu Q, Guo X. Antinociceptive effects of magnesium sulfate for monitored anesthesia care during hysteroscopy: a randomized controlled study. Bmc Anesthesiology. 20: 240. PMID 32957926 DOI: 10.1186/s12871-020-01158-9   
2020 Li D, Yoo JH, Kim SK. Long-Lasting and Additive Analgesic Effects of Combined Treatment of Bee Venom Acupuncture and Venlafaxine on Paclitaxel-Induced Allodynia in Mice. Toxins. 12. PMID 32998357 DOI: 10.3390/toxins12100620   
2020 Cuvillon P, Alonso S, L'Hermite J, Reubrecht V, Zoric L, Vialles N, Faillie JL, Kouyoumdjian P, Boisson C, Raux M, Langeron O. Post-operative opioid-related adverse events with intravenous oxycodone compared to morphine: a randomized controlled trial. Acta Anaesthesiologica Scandinavica. PMID 32790073 DOI: 10.1111/aas.13685   
2020 Behnood-Rod A, Chellian R, Wilson R, Hiranita T, Sharma A, Leon F, McCurdy CR, McMahon LR, Bruijnzeel AW. Evaluation of the rewarding effects of mitragynine and 7-hydroxymitragynine in an intracranial self-stimulation procedure in male and female rats. Drug and Alcohol Dependence. 215: 108235. PMID 32889450 DOI: 10.1016/j.drugalcdep.2020.108235   
2020 Castellanos DM, Sun J, Yang J, Ou W, Zambon AC, Pardridge WM, Sumbria RK. Acute and Chronic Dosing of a High-Affinity Rat/Mouse Chimeric Transferrin Receptor Antibody in Mice. Pharmaceutics. 12. PMID 32911688 DOI: 10.3390/pharmaceutics12090852   
2020 Goutaudier R, Coizet V, Carcenac C, Carnicella S. Compound 21, a two-edged sword with both DREADD-selective and off-target outcomes in rats. Plos One. 15: e0238156. PMID 32946510 DOI: 10.1371/journal.pone.0238156   
2020 Mizuno T, McPhail BT, Kamatkar S, Wexelblatt S, Ward L, Christians U, Akinbi HT, Vinks AA. Physiologic Indirect Response Modeling to Describe Buprenorphine Pharmacodynamics in Newborns Treated for Neonatal Opioid Withdrawal Syndrome. Clinical Pharmacokinetics. PMID 32939690 DOI: 10.1007/s40262-020-00939-2   
2020 Adewumi AD, Maravilla JC, Alati R, Hollingworth SA, Hu X, Loveday B, Connor JP. Pharmaceutical opioids utilisation by dose, formulation, and socioeconomic status in Queensland, Australia: a population study over 22 years. International Journal of Clinical Pharmacy. PMID 32964404 DOI: 10.1007/s11096-020-01155-5